Polycystic ovarian syndrome (PCOS) patients have a favorable response to ganirelix acetate during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF)-embryo transfer (ET).

被引：3
|
作者：
Bracero, N [1 ]
Jurema, M [1 ]
Vlahos, N [1 ]
Kolp, L [1 ]
Garcia, J [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Endocrinol, Baltimore, MD 21205 USA
来源：
FERTILITY AND STERILITY | 2002年 / 78卷 / 03期
关键词：
D O I：
10.1016/S0015-0282(02)03782-2
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P99
引用
收藏
页码：S149 / S150
页数：2
相关论文
共 50 条
  • [1] Beneficial use of ganirelix in controlled ovarian hyperstimulation (COH) cycles in older women undergoing in vitro fertilization (IVF).
    Jurema, MW
    Posada, MN
    Bracero, NJ
    Vlahos, NP
    Garcia, JE
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S130 - S130
  • [2] Machine Learning approaches to Predicting Personalized Response to Controlled Ovarian Hyperstimulation (COH) During In Vitro Fertilization (IVF).
    Thukral, S.
    Sakkas, D.
    Vaughan, D. A.
    Toth, T. L.
    Penzias, A. S.
    Bhasin, S.
    Jasuja, R.
    [J]. HUMAN REPRODUCTION, 2019, 34 : 425 - 426
  • [3] Should women with poor prognostic factors for controlled ovarian hyperstimulation undergo in vitro fertilization (COH-IVF) using ganirelix?
    Posada, MN
    Jurema, MW
    Vlahos, NP
    Bracero, NJ
    Wallach, EE
    Garcia, JE
    [J]. FERTILITY AND STERILITY, 2001, 76 (03) : S131 - S131
  • [4] Liver and kidney function of patients undergoing to a controlled ovarian hyperstimulation (COH) during an in vitro fertilization (IVF) cycle
    Romito, Ilaria
    Gulino, Ferdinando A.
    Tuscano, Attilio
    Di Gregorio, L. M.
    Di Stefano, A.
    Leanza, Gianluca
    Leanza, Vito
    Palumbo, Marco A.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 146 - 146
  • [5] GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles
    Zhai, Xiang-Hong
    Zhang, Ping
    Wu, Feng-Xia
    Wang, An-Cong
    Liu, Pei-Shu
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (06) : 3097 - 3102
  • [6] Diagnosis of polycystic ovarian syndrome (PCOS) or endometriosis is associated with lower pregnancy rates in women undergoing in vitro fertilization and embryo transfer (IVF-ET).
    Mitwally, M. F.
    Imam, M.
    Fakih, M.
    Ashraf, M.
    Diamond, M. P.
    Abuzeid, M.
    [J]. FERTILITY AND STERILITY, 2007, 88 : S120 - S120
  • [7] Does the phenotype of polycystic ovary syndrome influence the ovarian response to controlled ovarian hyperstimulation for IVF?
    Robin, G.
    Grysole, C.
    Uk, A.
    Barbotin, A. L.
    Decanter, C.
    Dewailly, D.
    [J]. HUMAN REPRODUCTION, 2018, 33 : 466 - 467
  • [8] Impact of a GnRH antagonist (Ganirelix®) on the outcome of controlled ovarian hyperstimulation (COH) in PCOS patients:: A prospective and randomized study.
    Stadtmauer, LA
    Kariya, K
    Arslan, M
    Oehninger, S
    [J]. FERTILITY AND STERILITY, 2005, 84 : S314 - S314
  • [9] Pregnancy outcomes in women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF)
    Sterling, L.
    Liu, J.
    Sakhuja, A.
    Sierra, S.
    Okun, N.
    Greenblatt, E.
    [J]. HUMAN REPRODUCTION, 2015, 30 : 371 - 372
  • [10] Pretreatment of polycystic ovarian syndrome (PCOS) patients with Metformin optimizes results front the clinical application of in vitro maturation, in vitro fertilization and embryo transfer (IVM-IVF).
    Fukuda, AI
    Kanaya, H
    Oku, H
    Nagata, H
    Nakaoka, Y
    Morimoto, Y
    [J]. FERTILITY AND STERILITY, 2004, 82 : S49 - S50
12345